B
173.21
-1.95 (-1.11%)
| 前收盘价格 | 175.16 |
| 收盘价格 | 174.64 |
| 成交量 | 375 |
| 平均成交量 (3个月) | 3,814 |
| 市值 | 46,837,714,944 |
| 市盈率 (P/E TTM) | 27.35 |
| 52周波幅 | |
| 利润日期 | 7 Aug 2025 |
| 股息率 (DY TTM) | 2.27% |
| 营业毛利率 | 7.18% |
| 营业利益率 (TTM) | 16.01% |
| 稀释每股收益 (EPS TTM) | 6.33 |
| 季度收入增长率 (YOY) | 4.50% |
| 季度盈利增长率 (YOY) | -42.60% |
| 总债务/股东权益 (D/E MRQ) | 76.34% |
| 流动比率 (MRQ) | 1.13 |
| 营业现金流 (OCF TTM) | 3.30 B |
| 杠杆自由现金流 (LFCF TTM) | 3.50 B |
| 资产报酬率 (ROA TTM) | 3.69% |
| 股东权益报酬率 (ROE TTM) | 5.89% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (GB) | 混合的 | 混合的 |
| Medical Instruments & Supplies (全球的) | 看跌 | 看跌 | |
| 股票 | BECTON DICKINSON AND CO BECTON | - | - |
AIStockmoo 评分
1.5
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 3.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 1.50 |
相关股票
| 股票 | 市值 | DY | P/E（TTM） | P/B |
|---|---|---|---|---|
| BECTON DICKINSON AND CO BECTON | 47 B | 2.27% | 27.35 | - |
| RESMED INC RESMED ORD SHS | 35 B | 0.80% | 47.35 | - |
| HOLOGIC INC HOLOGIC ORD SHS | 16 B | - | 10.10 | - |
| CONVATEC GROUP PLC ORD 10P | 5 B | 0.02% | 37.49 | 4.38 |
| COOPER COMPANIES INC COOPER ORD | 4 B | - | 4.31 | - |
| TECAN GROUP AG TECAN GROUP ORD | 2 B | 1.87% | 16.55 | - |
|
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Mid Core |
| 内部持股比例 | 0.56% |
| 机构持股比例 | 92.62% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合